288 related articles for article (PubMed ID: 30027469)
41. From the Cover: Tributyltin Alters the Bone Marrow Microenvironment and Suppresses B Cell Development.
Baker AH; Wu TH; Bolt AM; Gerstenfeld LC; Mann KK; Schlezinger JJ
Toxicol Sci; 2017 Jul; 158(1):63-75. PubMed ID: 28398592
[TBL] [Abstract][Full Text] [Related]
42. Small heterodimer partner-interacting leucine zipper protein inhibits adipogenesis by regulating peroxisome proliferator-activated receptor γ activity.
Jang H; Kim HJ; Kim DH; Park JK; Sun WS; Hwang S; Oh KB; Jang WG; Lee JW
Life Sci; 2015 Jul; 132():49-54. PubMed ID: 25896661
[TBL] [Abstract][Full Text] [Related]
43. 20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism.
Kim WK; Meliton V; Amantea CM; Hahn TJ; Parhami F
J Bone Miner Res; 2007 Nov; 22(11):1711-9. PubMed ID: 17638575
[TBL] [Abstract][Full Text] [Related]
44. PPARγΔ5, a Naturally Occurring Dominant-Negative Splice Isoform, Impairs PPARγ Function and Adipocyte Differentiation.
Aprile M; Cataldi S; Ambrosio MR; D'Esposito V; Lim K; Dietrich A; Blüher M; Savage DB; Formisano P; Ciccodicola A; Costa V
Cell Rep; 2018 Nov; 25(6):1577-1592.e6. PubMed ID: 30404011
[TBL] [Abstract][Full Text] [Related]
45. Acute genome-wide effects of rosiglitazone on PPARγ transcriptional networks in adipocytes.
Haakonsson AK; Stahl Madsen M; Nielsen R; Sandelin A; Mandrup S
Mol Endocrinol; 2013 Sep; 27(9):1536-49. PubMed ID: 23885096
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3.
Chan SS; Schedlich LJ; Twigg SM; Baxter RC
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E654-63. PubMed ID: 19141684
[TBL] [Abstract][Full Text] [Related]
47. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S
Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009
[TBL] [Abstract][Full Text] [Related]
48. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes.
Camp HS; Chaudhry A; Leff T
Endocrinology; 2001 Jul; 142(7):3207-13. PubMed ID: 11416043
[TBL] [Abstract][Full Text] [Related]
49. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
[TBL] [Abstract][Full Text] [Related]
50. The DLK gene is a transcriptional target of PPARγ.
Couture JP; Blouin R
Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338
[TBL] [Abstract][Full Text] [Related]
51. Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum.
Edwards L; Watt J; Webster TF; Schlezinger JJ
Environ Health; 2019 May; 18(1):45. PubMed ID: 31072366
[TBL] [Abstract][Full Text] [Related]
52. Organotin mixtures reveal interactions that modulate adipogenic differentiation in 3T3-L1 preadipocytes.
Ticiani E; Pu Y; White M; Adomshick V; Veiga-Lopez A
Arch Toxicol; 2023 Jun; 97(6):1649-1658. PubMed ID: 37142754
[TBL] [Abstract][Full Text] [Related]
53. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
[TBL] [Abstract][Full Text] [Related]
54. Tributyltin chloride leads to adiposity and impairs metabolic functions in the rat liver and pancreas.
Bertuloso BD; Podratz PL; Merlo E; de Araújo JF; Lima LC; de Miguel EC; de Souza LN; Gava AL; de Oliveira M; Miranda-Alves L; Carneiro MT; Nogueira CR; Graceli JB
Toxicol Lett; 2015 May; 235(1):45-59. PubMed ID: 25819109
[TBL] [Abstract][Full Text] [Related]
55. Grape pomace extract induced beige cells in white adipose tissue from rats and in 3T3-L1 adipocytes.
Rodriguez Lanzi C; Perdicaro DJ; Landa MS; Fontana A; Antoniolli A; Miatello RM; Oteiza PI; Vazquez Prieto MA
J Nutr Biochem; 2018 Jun; 56():224-233. PubMed ID: 29631143
[TBL] [Abstract][Full Text] [Related]
56. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).
Stechschulte LA; Ge C; Hinds TD; Sanchez ER; Franceschi RT; Lecka-Czernik B
J Biol Chem; 2016 Nov; 291(47):24475-24486. PubMed ID: 27687725
[TBL] [Abstract][Full Text] [Related]
57. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis.
Nielsen R; Pedersen TA; Hagenbeek D; Moulos P; Siersbaek R; Megens E; Denissov S; Børgesen M; Francoijs KJ; Mandrup S; Stunnenberg HG
Genes Dev; 2008 Nov; 22(21):2953-67. PubMed ID: 18981474
[TBL] [Abstract][Full Text] [Related]
58. Dlx5 Represses the Transcriptional Activity of PPARγ.
Kim CY; Cho DH; Chung DJ; Lee SH; Han Y; Lee KY
Biol Pharm Bull; 2021; 44(9):1303-1308. PubMed ID: 34471058
[TBL] [Abstract][Full Text] [Related]
59. BNIP3 is essential for mitochondrial bioenergetics during adipocyte remodelling in mice.
Choi JW; Jo A; Kim M; Park HS; Chung SS; Kang S; Park KS
Diabetologia; 2016 Mar; 59(3):571-81. PubMed ID: 26693709
[TBL] [Abstract][Full Text] [Related]
60. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells.
Li Y; Rong Y; Bao L; Nie B; Ren G; Zheng C; Amin R; Arnold RD; Jeganathan RB; Huggins KW
Lipids Health Dis; 2017 Sep; 16(1):181. PubMed ID: 28946872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
